Furthermore, HMGB1 is able to induce maturation of DCs, implying that chemoradiation induces tumor antigen-specific T cell responses, and that chemoradiation-mediated HMGB1 production is related to clinical outcome (Suzuki et al., 2012). The gene discussed is HMGB1; the disease is neoplasm.